Total Live Articles: 385

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Overview of Water Balance Disorders

These 2 tables act as an overview to allow comparison between confusing water balance disorders. They do not contain all the information about these disorders; please review their separate articles for full details.

Feature SIADH Primary Polydipsia Diabetes Insipidus (DI)
Pathophysiology Excess ADH secretion causes water retention Excess water intake suppresses ADH secretion Deficiency (central) or resistance (nephrogenic) to ADH
Typical causes CNS disorder, malignancy, drugs Psychogenic Central: brain tumour
Nephrogenic: drugs, renal disease
Serum sodium (baseline) Hyponatraemia Hypernatraemia
Serum osmolality (baseline) Low (<275 mOsm/kg) High (>295 mOsm/kg)
Urine osmolality (baseline) High (concentrated) (>100 mOsm/kg) Low (diluted) (<100 mOsm/kg)
Diagnosis Diagnosis by exclusion + supported by:

  • Euvolaemic isotonic hyponatraemia
  • Paired serum and urine osmolality findings (as above)

No role of water deprivation test and desmopressin administration

Detailed fluid intake history

Post-water deprivation test:

  • Urine concentrates (urine osmolality increases)

Post-desmopressin test:

  • Urine remains concentrated
Post-water deprivation test:

  • Urine osmolality does not change (stays low)

Post-desmopressin test:

  • Central DI: urine concentrates (urine osmolality increases)
  • Nephrogenic DI: no change (urine osmolality stages low)

Some key trends, but presented in a different way:

Disorder Trends (at baseline)
SIADH
  • Hyponatraemia
  • ↓ Serum osmolality
  • ↑ Urine osmolality (concentrated urine)
Primary polydipsia
  • Hyponatraemia
  • ↓ Serum osmolality
  • ↓ Urine osmolality (diluted urine)
Diabetes insipidus
  • Hypernatraemia
  • ↑ Serum osmolality
  • ↓ Urine osmolality

Definition

SIADH is defined as a disorder characterised by non-physiologic, excessive secretion of ADH​​​​​​.

Pathophysiology

Physiology of ADH: [Ref]

  • A hormone synthesised in the hypothalamus and secreted from the posterior pituitary gland
  • Function: acts on the collecting duct (via vasopressin 2 receptor) to increase expression of aquaporins → increase water reabsorption
  • ADH secretion is stimulated by ↑ serum osmolality and ↓ effective arterial blood volume

In SIADH, there is inappropriate excess ADH secretion (in the absence of appropriate stimuli), leading to: [Ref]

  • Impaired renal excretion of water (kidney retains more water than needed), and
  • Dilutional hyponatraemia

Aetiology

Selected causes of SIADH, this is not an exhaustive list: [Ref]

Category Causes
Malignancy (~25% cases of SIADH caused by cancer)
  • Small-cell lung cancer (most common)
Respiratory
  • Pneumonia (most common)
  • Acute respiratory failure
  • Positive pressure ventilation
CNS
  • Subarachnoid haemorrhage (most common)
  • Trans-sphenoidal surgery
  • Brain tumours
  • Head trauma
Drugs Some important and common ones:

  • SSRI – most common
  • PPIs
  • Carbamazepine
  • Cyclophosphamide
  • Vincristine
  • Desmopressin, oxytocin
  • MDMA (ecstasy) – intoxication can result in severe hyponatraemia

Clinical Features

Apart from features of the underlying cause, SIADH mainly presents as hyponatraemia [Ref]

  • Moderately severe cases: nausea (without vomiting), confusion, headache
  • Severe cases: vomiting, abnormal and deep somnolence, cardiorespiratory depression, seizures, coma, hyporeflexia

SIAH is characteristically euvolaemic (in terms of fluid status) [Ref]

  • There will be NO features of hypervolaemia (e.g. raised JVP, peripheral oedema, bi-basal crackles) or hypovolaemia (reduced skin turgor, dry mucous membrane, hypotension, tachycardia)
  • This is less realistic in real life, but in exams the parameters are typically perfect, and there will be either no mention of hypervolaemic / hypovoalemic features, or denial of them

Investigation and Diagnosis

SIADH can be diagnosed if ALL the following are present: [Ref]

  • Clinical euvolaemia
  • Hypotonic hyponatraemia (↓ serum osmolality <275 mmol/kg, serum sodium <135 mmol/L)
  • Inappropriately concentrated urine (urine osmolality >100-300 mmol/kg)
  • ↑ Urine sodium (>20 mmol/L)
  • Adrenal insufficiency and hypothyroidism are excluded

Important differentials of euvolaemic hypotonic hyponatraemia:

  • Adrenal insufficiency – can be excluded with a morning cortisol level
  • Severe hypothyroidism – can be excluded with TFT
  • Primary polydipsia

Primary polydipsia can have similar biochemical findings as SIADH:

  • Euvolaemic hypotonic hyponatraemia (same as SIADH)
  • Low urine sodium (NB urine sodium is high in SIADH)
  • Low urine osmolality (NB urine osmolality is high in SIADH)
  • The low urine sodium and osmolality will be corrected after a water deprivation test
  • A history of excessive water intake is also suggestive of primary polydipsia

Management

[Ref]

Step 1 Identify and treat any reversible causes (e.g. stop causative medications, treatment of malignancy)
Step 2 Fluid restriction (typically 1.0-1.5 L per day)
Step 3 (if refractory to fluid restriction) Consider:

  • Tolvaptan (vasopressin V2 receptor antagonist) – highly effective
  • Other options with lower efficacy
    • Empagliflozin (SGLT-2 inhibitor)
    • Oral urea
    • Salt tablets +/- loop diuretic
    • Increase dietary protein intake

Be aware that severe, symptomatic hyponatraemia (<120 mmol/L) requires emergency treatment with hypertonic saline.

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Be first to accessour QBank

Sign up to receive major guideline updates and early access when we launch.